From: End-of-life care of patients with idiopathic pulmonary fibrosis
No. (%) | |
---|---|
Patients | 59 |
Male | 32 (54 %) |
Age, mean (range) | 77 (56–91) |
Years from diagnose to death, mean (SD) | 3,7 (2,9) |
Smoking | |
Never | 26 (44 %) |
Former | 28 (48 %) |
Current | 2 (3 %) |
Missing data | 3 (5 %) |
Comorbidities | |
Cardiovascular disease | 40 (68 %) |
Hypertension | 28 (48 %) |
Diabetes mellitus | 17 (29 %) |
Atrial fibrillation | 13 (22 %) |
Obstructive lung disease | 12 (20 %) |
Cancer | 10 (17 %) |
Comorbidities per patient | |
None | 4 (7 %) |
1–2 | 21 (36 %) |
3–4 | 29 (49 %) |
> 5 | 5 (9 %) |
Place of death | |
Tertiary hospital (ward) | 23 (39 %) |
Tertiary hospital (ICU) | 3 (5 %) |
Community hospital | 21 (36 %) |
Home | 8 (14 %) |
Hospice | 1 (2 %) |
Nursing home | 3 (5 %) |
Cause of death recorded in death certificates | |
IPF | 42 (71 %) |
Cardiovascular diseases | 7 (12 %) |
Cancer | 6 (10 %) |
Other | 4 (7 %) |
Hospital admissions during the last 6 months of life, median (range) | |
Hospital ward visits | 2 (0–6) |
Length of stay per visit (days) | 11 (1–48) |
Length of final stay (days) | 9 (1–77) |